Latest clinical studies and research on joint pain treatments and outcomes.
Arthrosamid is the knee injection everyone is searching for in 2026. Learn what it is, why interest is surging, realistic expectations, and when it might be available in the US.
Current FDA status of Arthrosamid for US patients in 2026, clinical trial pathway, estimated approval timeline, and what alternatives are available now.
Research confirms repeated cortisone injections accelerate cartilage breakdown. RSNA findings and safer alternatives.
The latest research on knee cartilage regeneration in 2026 including gene therapy, piezoelectric gel, MACI, and what treatments are actually available now.
Hard data on knee injection success rates by type including gel shots, cortisone, and PRP. Factors that affect outcomes and how to improve your chances.
Annual review of the viscosupplementation market in 2026. Coverage changes, new products, research highlights, and trends shaping HA injection treatment.
STEP-9 trial: semaglutide cut knee OA pain 59% vs placebo. Review of GLP-1 evidence for joint pain, costs, Medicare limits, and how it compares to other treatments.
Knee embolization (geniculate artery embolization) is an emerging minimally invasive procedure for knee osteoarthritis pain. Learn how GAE works, clinical evidence, costs, and who may benefit.
A deep dive into what clinical research actually shows about gel injections (viscosupplementation) for knee osteoarthritis, including pain relief data, responder rates, and why guidelines conflict despite positive evidence.
Considering knee replacement over 65? Understand the real risks, how age affects outcomes, and what alternatives might reduce your exposure while still providing relief.
A 2025 network meta-analysis of 71 RCTs and 10,590 patients confirms HA injection efficacy for knee OA. Review the latest research on hybrid formulations and treatment outcomes.
A comprehensive evidence-based report on why Blue Cross Blue Shield of Illinois should maintain Medicare Advantage coverage for viscosupplementation (HA injections) in 2026. Includes clinical efficacy data, cost-effectiveness analysis, and policy comparisons.
Browse all our joint health articles or explore other categories.
No results found
Try adjusting your search or
We use cookies to improve your experience, analyze site traffic, and personalize content. You can customize your preferences or accept all cookies. Learn more in our Privacy Policy .
Required for the website to function properly. These cannot be disabled. Includes session management and security features.
Help us understand how visitors interact with our website. We use this data to improve content and user experience.
Used to deliver relevant advertisements and track campaign effectiveness. May be set by our advertising partners.